ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,074,000 | -47.7% | 39,600 | -50.0% | 0.00% | 0.0% |
Q2 2021 | $2,054,000 | +0.2% | 79,200 | -16.9% | 0.00% | -50.0% |
Q4 2020 | $2,050,000 | +20.0% | 95,354 | -17.7% | 0.01% | 0.0% |
Q3 2020 | $1,708,000 | -67.0% | 115,800 | -50.1% | 0.01% | -40.0% |
Q2 2020 | $5,182,000 | +238.7% | 231,944 | +114.1% | 0.01% | +150.0% |
Q1 2020 | $1,530,000 | -68.0% | 108,344 | -20.6% | 0.00% | -60.0% |
Q3 2019 | $4,774,000 | -38.7% | 136,420 | -1.2% | 0.01% | -33.3% |
Q2 2019 | $7,792,000 | +19.3% | 138,096 | +54.4% | 0.02% | -42.3% |
Q1 2019 | $6,532,000 | +29.0% | 89,412 | +12.6% | 0.03% | +18.2% |
Q4 2018 | $5,065,000 | -27.0% | 79,408 | +14.1% | 0.02% | -12.0% |
Q3 2018 | $6,942,000 | +381.1% | 69,583 | +242.5% | 0.02% | +316.7% |
Q2 2018 | $1,443,000 | -30.9% | 20,315 | +1.3% | 0.01% | -25.0% |
Q1 2018 | $2,088,000 | – | 20,057 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |